Overview
Practice
About
Publications
Fiaz Zaman, MD, FACS
See More
See More
See More
See More
See More
See More
See More
See More
Last updated on: 11/30/2025
Dr. Fiaz Zaman is a distinguished ophthalmologist dedicated to providing exceptional eye care. With extensive training from the University of Pennsylvania, University of Missouri-Kansas City School of Medicine, and fellowships at Houston Eye Associates, Dr. Zaman brings a wealth of knowledge and experience to his practice. He specializes in a comprehensive range of services, including general ophthalmology, glaucoma management, cataract surgery, and retinal disease treatment. Dr....
In-network insurance plans
Appointments Scheduling
Houston Eye Associates
Address:
Fax:
(713) 558-8795
Houston Eye Associates
Univ. of Houston System
Address:
Fax:
(713) 743-0963
Houston Optic PLLC
Address:
Fax:
(281) 465-4261
Dr. Fiaz Zaman treats a variety of eye conditions, including Dry Eye, Glaucoma, Cataract, Conjunctivitis, and Vision Problems, among others.
Dr. Fiaz Zaman's specialties include Ophthalmology, General Ophthalmology, Glaucoma Related, and Retinal Disease.
Dr. Fiaz Zaman completed residencies at University Tx Med Branch John Sealy Hospital, Univ Tx Med Branch Hosps, Ophthalmology; Vet Affairs Lakeside M C, Internal Medicine, and Northwestern Mem Hospital, among others.
Patients can find Dr. Fiaz Zaman at Houston Eye Associates, Univ. of Houston System, and Houston Optic PLLC, with locations in Houston and Shenandoah, TX.
Yes, Dr. Fiaz Zaman is accepting new patients.
Dr. Fiaz Zaman is affiliated with Memorial Hermann Northeast Hospital, Memorial Hermann Memorial City Medical Center, Memorial Hermann-Texas Medical Center, HCA Houston Healthcare Northwest, and Memorial Hermann Northwest Hospital, among others.
Dr. Fiaz Zaman accepts Aetna, Ambetter, Anthem, Arkansas Blue Cross Blue Shield, and Blue Cross Blue Shield, among others.
Dr. Fiaz Zaman speaks English.
Yes, Dr. Fiaz Zaman has publications, including "A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting" and "Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials."
Aggregated from 13 comments